154 | ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA / Anest intenziv Med. 2024;35(3):142-154 / www.aimjournal.cz on for COVID-19. Acta Microbiol Immunol Hung. 2022;69:270-6. 7. Guerrero D, Baker T, Corn M, Keup S, Nickell A, Cao L. Association of vaccination status and severity of SARS‑CoV-2 infections in hospitalized patients. Vaccine X. 2024;18:100473. 8. Van Diepen S, McAlister FA, Chu LM, Youngson E, Kaul P, Kadri SS. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19. Crit Care Med. 2023;51:1201-9. 9. Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021. Prev Chronic, DiS. 2021;18:1-13. 10. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. 11. Zhou D, Wang C, Lin Q, Li T. The obesity paradox for survivors of critically ill patients. Crit Care. 2022;26. 12. Balik M, Svobodova E, Porizka M, Maly M, Brestovansky P, Volny L, et al. The impact of obesity on the outcome of severe SARS‑CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox. J Crit Care. 2022;72. 13. Barnes E, Goodyear CS, Willicombe M, Gaskell C, Siebert S, I de Silva T, et al. SARS ‑CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune‑suppressive disease. Nat Med. 2023;29:1760-74. 14. Kakkassery H, Carpenter E, Patten PEM, Irshad S. Immunogenicity of SARS‑CoV-2 vaccines in patients with cancer. Trends Mol Med. 2022;28:1082-99. 15. Lin TY, Hung NK, Hung SC. Association of malnutrition with SARS‑CoV-2 vaccine response in patients undergoing hemodialysis. Clin Nutr. 2022;41:2683-90. 16. Wang J, Tong Y, Li D, Li J, Li Y. The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta‑Analysis. Front Immunol. 2021;12. 17. Antwi‑Amoabeng D, Beutler BD, Ulanja MB, Neelam V, Gbadebo TD. Effect of atrial fibrillation on mortality in SARS‑CoV-2 patients: A propensity score‑matched analysis of nationwide hospitalizations in the United States. Heliyon. 2023;9. 18. Wong AYS, Tomlinson LA, Brown JP, Elson W, Walker AJ, Schultze A, et al. Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population‑based cohort study. J Hematol Oncol. 2021;14. 19. Einarsdottir MJ, Kibiwott Kirui B, Li H, Olsson D, Johannsson G, Nyberg F, et al. Impact of chronic oral glucocorticoid treatment on mortality in patients with COVID-19: analysis of a population‑based cohort. BMJ Open. 2024;14:e080640. 20. Ben Nessib D, Fazaa A, Miladi S, Sellami M, Ouenniche K, Souabni L, et al. Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature. Therapie. 2021;76:215-9. 21. Varea‑Jiménez E, Aznar Cano E, Vega‑Piris L, Martínez Sánchez EV, Mazagatos C, García San Miguel Rodríguez‑Alarcón L, et al. Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS‑CoV-2 variants and its association with vaccination. Enfermedades infecciosas y microbiologia clinica (English ed). 2024;42:187-94. 22. DeCuir J, Surie D, Zhu Y, Gaglani M, Ginde AA, Douin DJ, et al. Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19 – Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period‑IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:463-8. 23. Wu Z, Han Z, Liu B, Shen N. Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials. Front Pharmacol. 2022;13. 24. Godwin PO, Polsonetti B, Caron MF, Oppelt TF. Remdesivir for the Treatment of COVID-19: A Narrative Review. Infect Dis Ther. 2024;13:1-19. 25. Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, et al. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open‑label, platform trial. The Lancet. 2022;399:665-76. 26. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021;384:905-14. 27. Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Monoclonal antibody therapies against SARS‑CoV-2. Lancet Infect, DiS. 2022;22: e311-26. 28. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2021;384:693-704. 29. Bassetti M, Kollef MH, Timsit JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med. 2020;46:2071-4. 30. Iannizzi C, Chai KL, Piechotta V, Valk SJ, Kimber C, Monsef I, et al. Convalescent plasma for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2023;5. 31. Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open‑label, platform trial and updated meta‑analysis. Lancet. 2022;400:359-68. 32. Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, et al. Systematic Review and Meta‑Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. Int J Environ Res Public Health. 2021;18. 33. Wunsch H. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology. Am J Respir Crit Care Med. 2020;202:1-4. 34. Watts A, Polychronopoulou E, Neira DP. Trends in mechanical ventilation and mortality in hospitalized patients with COVID-19: a retrospective analysis. Chest. 2021;160:A1127. 35. Benes J, Jankowski M, Szułdrzynski K, Zahorec R, Lainscak M, Ruszkai Z, et al. SepsEast Registry indicates high mortality associated with COVID-19 caused acute respiratory failure in Central‑Eastern European intensive care units. Sci Rep. 2022;12. 36. Kim TW, Kim WY, Park S, Lee SH, Park O, Kim T, et al. Risk Factors for the Mortality of Patients With Coronavirus Disease 2019 Requiring Extracorporeal Membrane Oxygenation in a Non‑Centralized Setting: A Nationwide Study. J Korean Med Sci. 2024;39:e75. 37. Qaddoura A, Bartoszko J, Mitchell R, Frenette C, Johnston L, Mertz D, et al. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome in Canada: Analysis of data from the Canadian Nosocomial Infection Surveillance Program. J Assoc Med Microbiol Infect Dis Can. 2024;8:272-82. PŮVODNÍ PRÁCE / ORIGINAL PAPER Analýza rizikových faktorů a vliv specifické terapie na klinický výsledek pacientů hospitalizovaných pro covid-19 na pracovištích univerzitního typu v České republice Nemocnice Sokolov hledá lékaře ANESTEZIOLOGA A INTENZIVISTU Připojte se k našemu dynamickému týmu v prestižím akreditovaném soukromém zdravotnickém zařízení. Nabízíme skvělou příležitost stát se součástí týmu, kde je kladen důraz na kvalitu péče a spokojenost našich pacientů i kolegů. Přijďte s námi tvořit budoucnost zdravotnictví a užijte si práci, která má smysl. Přineste své zkušenosti právě k nám a budete mít možnost se aktivně podílet na rozvoji intenzivní péče a realizovat své vlastní nápady. Ať už jste čerstvý absolvent nebo zkušený odborník, pokud máte vášeň pro anesteziologii a intenzivní péči, rádi Vás přivítáme do našeho týmu. Jsme připraveni Vás plně zaškolit a podpořit ve Vašem profesním růstu. Kontakt: Bc. Andrea Novotná, tel.: 605 322 498, e-mail: andrea.novotna@nemocnicesokolov.cz www.pentahospitals.cz leták_ARO_180 x 80 mm_c.indd 1 05.08.2024 11:33:58
RkJQdWJsaXNoZXIy NDA4Mjc=